Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The 23 Optimized Patients

<< Previous

Bullboard Posts

Next >>

Comment by stocksnbonds458on Apr 05, 2022 2:43pm

209 Views

Post# 34577738

RE:RE:The 23 Optimized Patients

For me, the only relevant data is the 23 optimized patients in phase two- these are the ONLY numbers I have been waiting for. After 90 days 52.2% of these 23 patients is CR according to TLT. This as an ABSOLUTELY ASTOUNDING number. For them to say encouraging instead of doing backflips and shouting from the building tops is because they are playing it low key for obvious reasons. This is game changing

<< Previous

Bullboard Posts

Next >>

Geologica Resource: Polymetallic upside at a depressed price